دورية أكاديمية
أعرض في EDS

Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling.

التفاصيل البيبلوغرافية
العنوان: Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling.
المؤلفون: Chen Q; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Jiang LY; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Cao C; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Liu FY; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Li DR; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Wu PF; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Jiang KR; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
المصدر: Molecular carcinogenesis [Mol Carcinog] 2024 May; Vol. 63 (5), pp. 938-950. Date of Electronic Publication: 2024 Feb 14.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE
أسماء مطبوعة: Publication: <2005- > : [Hoboken, N.J.] : Wiley-Liss
Original Publication: New York : Alan R. Liss, Inc., c1988-
مواضيع طبية MeSH: Adenine Nucleotides* , Carcinoma, Pancreatic Ductal*/genetics , Carcinoma, Pancreatic Ductal*/pathology , Pancreatic Neoplasms*/genetics , Pancreatic Neoplasms*/pathology , Glycoproteins*/metabolism , 2',5'-Oligoadenylate Synthetase*/metabolism, Humans ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Carrier Proteins/metabolism
مستخلص: Pancreatic ductal adenocarcinoma (PDAC) is a highly invasive cancer with a poor prognosis and a 5-year survival rate of less than 11%. As a member of the CAP superfamily of proteins, the role of peptidase inhibitor 16 (Pi16) in tumor progression is still unclear. Immunohistochemistry and quantitative RT-PCR methods were used to detect the expression levels of Pi16 protein and mRNA in PDAC patients. CRISPR/Cas9 technology was used to knock out the expression of Pi16 in PDAC cell lines. In vivo and in vitro experiments were used to verify the effect of Pi16 on PDAC proliferation ability. By RNA sequencing, we found that oligoadenylate synthetase L (OASL) can serve as a potential downstream target of Pi16. The expression of Pi16 was higher in PDAC tissues than in matched adjacent tissues. High expression of Pi16 was associated with PDAC progression and poor prognosis. Overexpression of Pi16 could promote the proliferation of PDAC cells in vitro and in vivo. Bioinformatics analysis and coimmunoprecipitation assays showed that Pi16 could bind to OASL. Moreover, the functional recovery test confirmed that Pi16 could promote the proliferation of PDAC via OASL. Our present study demonstrates that Pi16 might participate in the occurrence and development of PDAC by regulating cell proliferation by binding to OASL, indicating that Pi16 might be a promising novel therapeutic target for PDAC.
(© 2024 Wiley Periodicals LLC.)
References: Li O, Li L, Sheng Y, et al. Biological characteristics of pancreatic ductal adenocarcinoma: initiation to malignancy, intracellular to extracellular. Cancer Lett. 2023;574:216391.
Zou X, Lin X, Cheng H, et al. Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance. J Immunother Cancer. 2023;11:e006698.
Ding J, Qiu J, Hao Z, et al. Comparing the clinical value of baseline [Ga]Ga‐FAPI‐04 PET/CT and [F]F‐FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitis. Eur J Nucl Med Mol Imaging. 2023;50(13):4036‐4050.
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17‐48.
Reeves JR, Xuan JW, Arfanis K, et al. Identification, purification and characterization of a novel human blood protein with binding affinity for prostate secretory protein of 94 amino acids. Biochem J. 2005;385(Pt 1):105‐114.
Gibbs GM, Roelants K, O'Bryan MK. The CAP superfamily: cysteine‐rich secretory proteins, antigen 5, and pathogenesis‐related 1 proteins—roles in reproduction, cancer, and immune defense. Endocr Rev. 2008;29(7):865‐897.
Ma J, Yan B, Zhang J, et al. PSP94, an upstream signaling mediator of prostasin found highly elevated in ovarian cancer. Cell Death Dis. 2014;5(9):e1407.
Regn M, Laggerbauer B, Jentzsch C, et al. Peptidase inhibitor 16 is a membrane‐tethered regulator of chemerin processing in the myocardium. J Mol Cell Cardiol. 2016;99:57‐64.
Lupsa N, Érsek B, Horváth A, et al. Skin‐homing CD8(+) T cells preferentially express GPI‐anchored peptidase inhibitor 16, an inhibitor of cathepsin K. Eur J Immunol. 2018;48(12):1944‐1957.
Wang P, Jiang Z, Liu X, et al. PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma. Cancer Med. 2020;9(19):6972‐6983.
Kuang X, Zhang Z, Li D, et al. Peptidase inhibitor (PI16) impairs bladder cancer metastasis by inhibiting NF‐κB activation via disrupting multiple‐site ubiquitination of NEMO. Cell Mol Biol Lett. 2023;28(1):62.
Reeves JR, Dulude H, Panchal C, Daigneault L, Ramnani DM. Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy. Clin Cancer Res. 2006;12(20 Pt 1):6018‐6022.
Ghosh A, Shao L, Sampath P, et al. Oligoadenylate‐synthetase‐family protein OASL inhibits activity of the DNA sensor cGAS during DNA virus infection to limit interferon production. Immunity. 2019;50(1):51‐63.
Lv J, Wang L, Shen H, Wang X. Regulatory roles of OASL in lung cancer cell sensitivity to Actinidia chinensis planch root extract (acRoots). Cell Biol Toxicol. 2018;34(3):207‐218.
Zhang Y, Yu C. Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer. BMC Cancer. 2020;20(1):575.
Zhao W, Yang H, Liu L, et al. OASL knockdown inhibits the progression of stomach adenocarcinoma by regulating the mTORC1 signaling pathway. FASEB J. 2023;37(3):e22824.
Gao L, Ren R, Shen J, et al. Values of OAS gene family in the expression signature, immune cell infiltration and prognosis of human bladder cancer. BMC Cancer. 2022;22(1):1016.
Zhang C, Zou Y, Zhu Y, et al. Three immune‐related prognostic mRNAs as therapeutic targets for pancreatic cancer. Front Med. 2021;8:649326.
Chen Q, Shen P, Ge WL, et al. Roundabout homolog 1 inhibits proliferation via the YY1‐ROBO1‐CCNA2‐CDK2 axis in human pancreatic cancer. Oncogene. 2021;40(15):2772‐2784.
Ledford H. Super‐precise CRISPR tool enters US clinical trials for the first time. Nature. 2023;621(7980):667‐668.
Liu Z, Shi M, Ren Y, et al. Recent advances and applications of CRISPR‐Cas9 in cancer immunotherapy. Mol Cancer. 2023;22(1):35.
Zhang G, Luo Y, Dai X, Dai Z. Benchmarking deep learning methods for predicting CRISPR/Cas9 sgRNA on‐ and off‐target activities. Brief. Bioinform. 2023;24(6):bbad333.
Frost RJA, Engelhardt S. A secretion trap screen in yeast identifies protease inhibitor 16 as a novel antihypertrophic protein secreted from the heart. Circulation. 2007;116(16):1768‐1775.
Deng M, Yang S, Ji Y, et al. Overexpression of peptidase inhibitor 16 attenuates angiotensin II‐induced cardiac fibrosis via regulating HDAC1 of cardiac fibroblasts. J Cell Mol Med. 2020;24(9):5249‐5259.
Wang L, Du A, Lu Y, et al. Peptidase inhibitor 16 attenuates left ventricular injury and remodeling after myocardial infarction by inhibiting the HDAC1‐Wnt3a‐β‐Catenin signaling axis. J Am Heart Assoc. 2023;12(10):e028866.
Chen R, Eshleman JR, Brodsky RA, Medof ME. Glycophosphatidylinositol‐anchored protein deficiency as a marker of mutator phenotypes in cancer. Cancer Res. 2001;61(2):654‐658.
Vidal M. Exosomes and GPI‐anchored proteins: judicious pairs for investigating biomarkers from body fluids. Adv Drug Deliv Rev. 2020;161‐162:110‐123.
Nicholson IC, Mavrangelos C, Bird DRG, et al. PI16 is expressed by a subset of human memory Treg with enhanced migration to CCL17 and CCL20. Cell Immunol. 2012;275(1‐2):12‐18.
Gaikwad AS, Hu J, Chapple DG, O'Bryan MK. The functions of CAP superfamily proteins in mammalian fertility and disease. Hum Reprod Update. 2020;26(5):689‐723.
Elyada E, Bolisetty M, Laise P, et al. Cross‐species single‐cell analysis of pancreatic ductal adenocarcinoma reveals antigen‐presenting cancer‐associated fibroblasts. Cancer Discov. 2019;9(8):1102‐1123.
Bear AS, Vonderheide RH, O'Hara MH. Challenges and opportunities for pancreatic cancer immunotherapy. Cancer Cell. 2020;38(6):788‐802.
Crawford NPS, Walker RC, Lukes L, Officewala JS, Williams RW, Hunter KW. The Diasporin Pathway: a tumor progression‐related transcriptional network that predicts breast cancer survival. Clin Exp Metastasis. 2008;25(4):357‐369.
Hazell GGJ, Peachey AMG, Teasdale JE, et al. PI16 is a shear stress and inflammation‐regulated inhibitor of MMP2. Sci Rep. 2016;6:39553.
Sarkar SN, Harioudh MK, Shao L, Perez J, Ghosh A. The many faces of oligoadenylate synthetases. J Interferon Cytokine Res. 2023;43(11):487‐494.
Chang SC, Zhang BX, Su ECY, et al. Hiltonol cocktail kills lung cancer cells by activating cancer‐suppressors, PKR/OAS, and restraining the tumor microenvironment. Int J Mol Sci. 2021;22(4):1626.
Lee D, Le Pen J, Yatim A, et al. Inborn errors of OAS‐RNase L in SARS‐CoV‐2‐related multisystem inflammatory syndrome in children. Science. 2023;379(6632):eabo3627.
Gao LJ, Li JL, Yang RR, et al. Biological characterization and clinical value of OAS gene family in pancreatic cancer. Front Oncol. 2022;12:884334.
معلومات مُعتمدة: 82103280 National Natural Science Foundation of China; 81871980 National Natural Science Foundation of China; BM2015004 Innovation Capability Development Project of Jiangsu Province; JX10231801 Priority Academic Program Development of Jiangsu Higher Education Institutions
فهرسة مساهمة: Keywords: OASL; PDAC; Pi16; proliferation; therapeutic target
المشرفين على المادة: 0 (Adenine Nucleotides)
0 (PI16 protein, human)
0 (Glycoproteins)
0 (Carrier Proteins)
EC 2.7.7.- (OASL protein, human)
EC 2.7.7.84 (2',5'-Oligoadenylate Synthetase)
تواريخ الأحداث: Date Created: 20240214 Date Completed: 20240415 Latest Revision: 20240425
رمز التحديث: 20240425
DOI: 10.1002/mc.23699
PMID: 38353288
قاعدة البيانات: MEDLINE
الوصف
تدمد:1098-2744
DOI:10.1002/mc.23699